Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing's Syndrome | Illinois
CHICAGO--(BUSINESS WIRE)--Jan 31, 2022--
Source: wsiltv.com